Pembrolizumab in Triple-Negative Breast Cancer

被引:0
|
作者
Altundag, Kadri [1 ]
机构
[1] MKA Breast Canc Clin, Ankara, Turkey
来源
NEW ENGLAND JOURNAL OF MEDICINE | 2022年 / 387卷 / 15期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
下载
收藏
页码:1435 / 1436
页数:2
相关论文
共 50 条
  • [21] Triple-negative breast cancer
    Stockmans, Gert
    Deraedt, Karen
    Wildiers, Hans
    Moerman, Philippe
    Paridaens, Robert
    CURRENT OPINION IN ONCOLOGY, 2008, 20 (06) : 614 - 620
  • [22] Triple-Negative Breast Cancer
    Foulkes, William D.
    Smith, Ian E.
    Reis-Filho, Jorge S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (20): : 1938 - 1948
  • [23] Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer
    Schmid, P.
    Cortes, J.
    Dent, R.
    Pusztai, L.
    McArthur, H.
    Kummel, S.
    Bergh, J.
    Denkert, C.
    Park, Y. H.
    Hui, R.
    Harbeck, N.
    Takahashi, M.
    Untch, M.
    Fasching, P. A.
    Cardoso, F.
    Andersen, J.
    Patt, D.
    Danso, M.
    Ferreira, M.
    Mouret-Reynier, M-A
    Im, S-A
    Ahn, J-H
    Gion, M.
    Baron-Hay, S.
    Boileau, J-F
    Ding, Y.
    Tryfonidis, K.
    Aktan, G.
    Karantza, V
    O'Shaughnessy, J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (06): : 556 - 567
  • [24] Triple-negative breast cancer
    Bartsch R.
    Ziebermayr R.
    Zielinski C.C.
    Steger G.G.
    Wiener Medizinische Wochenschrift, 2010, 160 (7-8) : 174 - 181
  • [25] Triple-Negative Breast Cancer
    Liedtke, Cornelia
    Schmutzler, Rita
    Schneeweiss, Andreas
    Loibl, Sybille
    Thill, Marc
    Heitz, Florian
    BREAST CARE, 2010, 5 (05) : 359 - 363
  • [26] Triple-negative breast cancer
    Reinaldo D Chacón
    María V Costanzo
    Breast Cancer Research, 12
  • [27] Triple-negative breast cancer
    Aschenbrenner, Diane S.
    AMERICAN JOURNAL OF NURSING, 2020, 120 (08) : 22 - 23
  • [28] Triple-Negative Breast Cancer: Not Entirely Negative
    Leone, Jose Pablo
    Puhalla, Shannon
    ONCOLOGY-NEW YORK, 2013, 27 (09): : 856 - +
  • [29] Chemokine modulation to enhance the effectiveness of pembrolizumab in patients with metastatic triple-negative breast cancer
    Abdou, Yara
    Kalinski, Pawel
    Opyrchal, Mateusz
    CANCER IMMUNOLOGY RESEARCH, 2019, 7 (02)
  • [30] Phase Ib trial of olinvacimab and pembrolizumab in patients with metastatic triple-negative breast cancer
    Chan, Arlene
    Moylan, Eugene
    Jackson, Sally
    Devoto, Jeannette
    Jones, Nicola
    Radmil, Silvie
    Wilkinson, Kate
    Roohullah, Aflah
    Adam, Tamiem
    Lee, Seon Young
    Lee, Weon Sup
    Yoo, Jin-San
    CANCER RESEARCH, 2021, 81 (04)